Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Genexiscell

WebsiteLinkedInTwittercbCrunchbase
Status
ACTIVE
Global HQ
São Paulo, Brazil
Countries of investment
  • Brazil
Investment stages
    Industries
    • Biotechnology
    • Health tech
    About
    Genexiscell is a biotechnology company specializing in cell therapy and regenerative medicine. The firm develops innovative treatments aimed at addressing a range of medical conditions, leveraging advanced research to improve patient outcomes.
    Min check size
    $100K
    Max check size
    $500K
    Fund size
    NPS

    Investment Thesis

    Genexiscell focuses on advancing cell therapy and regenerative medicine solutions, leveraging biotechnology to develop innovative treatments for various medical conditions.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method
    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp